Development and validation of a chromatographic method for determining Clematichinenoside AR and related impurities

Development and validation of a chromatographic method for determining Clematichinenoside AR and related impurities

<p>Abstract</p> <p>Background</p> <p>Clematichinenoside AR is a promising lead compound for the treatment of rheumatoid arthritis. A systematic research for the related impurities in AR bulk samples is still lacking. For the safe use of this natural product in future cl...

Full description

Bibliographic Details
Main Authors:	Zhou Yang, Guan Yue, Shi Ji, Zhang Xiaolin, Yao Lan, Liu Lifang
Format:	Article
Language:	English
Published:	BMC 2012-12-01
Series:	Chemistry Central Journal
Subjects:	Clematichinenoside AR Related impurities HPLC-UV Correction factors
Online Access:	http://journal.chemistrycentral.com/content/6/1/150

Similar Items

Succinate/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis
by: Yi Li, et al.
Published: (2016-12-01)

Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway
by: Haiyan Ding, et al.
Published: (2016-05-01)

Clematichinenoside serves as a neuroprotective agent against ischemic stroke: the synergistic action of ERK1/2 and cPKC pathways.
by: Chao eLiu, et al.
Published: (2016-01-01)

RECOMMENDATIONS OF THE EUROPEAN PHARMACOPOEIA «ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS» AND THEIR RESTRICTIONS FOR THE METHODS OF IMPURITIES DETERMINATION
by: N. A. Epshtein, et al.
Published: (2019-01-01)

Desenvolvimento e validação de método por cromatografia líquida de alta eficiência para determinação simultânea das impurezas timina e timidina na matéria-prima estavudina Development and validation of a high performance liquid chromatographic method for simultaneous determination of the impurities thymine and thymidine in stavudine bulk drug
by: Gisele Rodrigues da Silva, et al.
Published: (2008-01-01)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
by: Emanuela Scudellaro, et al.
Published: (2020-04-01)

Some aspects regarding impurities profile in fipronil-HPLC method
by: Ana Csuma,, et al.
Published: (2011-12-01)

Detection, isolation and characterization of principle synthetic route indicative impurity in telmisartan
by: V. Srinivasan, et al.
Published: (2016-11-01)

Development and Validation of Chromatographic Methods for Simultaneous Determination of Ibuprofen and Famotidine in Presence of Related Substances in Pharmaceutical Formulations
by: Eman S Elzanfaly, et al.
Published: (2014-11-01)

Development and validation of RP HPLC method for the estimation of Sofosbuvir and related impurity in bulk and pharmaceutical dosage form
by: Shiny Ganji, et al.
Published: (2021-07-01)

Validation of the method for determination of related impurities in the active antiviral ingredient of enisamium iodide
by: O. V. Burmaka, et al.
Published: (2018-10-01)

HPLC – Quality by Design Approach for Simultaneous Detection of Torsemide, Spironolactone and Their Degradant Impurities
by: Bihola Unnati, et al.
Published: (2018-08-01)

Impurity removal process for high-purity silica production by acid leaching
by: Ezzaouia H., et al.
Published: (2012-06-01)

CHROMATOGRAPHIC SYSTEM SUITABILITY TESTING: INFLUENCE OF CORRECTION FACTORS AND LATE ELUTING PEAKS OF IMPURITIES ON THE REQUIREMENT FOR THE SIGNAL-TO-NOISE RATIO (REVIEW)
by: N. A. Epshtein
Published: (2019-02-01)

Determination of Propionylbrassinolide and Its Impurities by High-Performance Liquid Chromatography with Evaporative Light Scattering Detection
by: Lidong Cao, et al.
Published: (2018-02-01)

Analysis and impurity identification in pharmaceuticals
by: Prajapati Prajesh, et al.
Published: (2014-08-01)

A developed HPLC method for the determination of Alogliptin Benzoate and its potential impurities in bulk drug and tablets
by: Kun Zhang, et al.
Published: (2015-04-01)

Removing metallic impurities from ferrosilicon alloy by Ar-O<sub>2</sub> gas blowing
by: ZHANG Yan-hui, et al.
Published: (2021-02-01)

Gradient high performance liquid chromatography method for simultaneous determination of ilaprazole and its related impurities in commercial tablets
by: Shang Wang, et al.
Published: (2015-04-01)

Improvement of Tests for the Control of Impurities in Antimicrobial Medicinal Products by Chromatographic Methods: Ciprofloxacin Case Study
by: S. I. Kuleshova, et al.
Published: (2018-12-01)

A rapid stability indicating LC-method for determination of praziquantel in presence of its pharmacopoeial impurities
by: Hisham Hashem, et al.
Published: (2017-02-01)

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar
by: Emilia Sawicki, et al.
Published: (2016-08-01)

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds
by: Shenghua Gao, et al.
Published: (2018-11-01)

Liquid chromatographic method for the determination of beta-carotene from milk and cheese
by: Anca Becze, et al.
Published: (2020-12-01)

Oligosaccharide Chromatographic Techniques for Quantitation of Structural Process-Related Impurities in Heparin Resulting From 2-O Desulfation
by: Pascal Anger, et al.
Published: (2018-12-01)

First impurity powder injection experiments in LHD
by: F. Nespoli, et al.
Published: (2020-12-01)

The impure and the intense
by: Andrea Mubi Brighenti
Published: (2015-06-01)

Seeds of impurity
by: Andrea Pavoni
Published: (2015-06-01)

Validation of a rapid and sensitive reversed-phase liquid chromatographic method for the quantification of prenylated chalcones and flavanones in plasma and urine
by: Nadine Sus, et al.
Published: (2018-03-01)

THE USE OF A CHROMATOGRAPHIC COLUMN PACKED WITH AMIDE SORBENT FOR THE ANALYSIS OF PARABENS
by: A. S. Osipov, et al.
Published: (2018-03-01)

Development of a reversed-phase HPLC method for determination of related impurities of Lenalidomide
by: Seyyed Amir Siadati, et al.
Published: (2020-04-01)

Validation of chromatographic analysis
by: Onjia Antonije E., et al.
Published: (2002-01-01)

DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD
by: T. N. Komarov, et al.
Published: (2019-01-01)

High performance liquid chromatography method development and validation for detection and quantification of substances related to alpha keto valine calcium salt
by: Ambasana, M., et al.
Published: (2021)

Genotoxic impurities in pharmaceutical products – regulatory, toxicological and pharmaceutical considerations
by: Katarzyna Regulska, et al.
Published: (2021-03-01)

Development and validation of a RP-HPLC method to determine the xanthyletin content in biodegradable polymeric nanoparticles
by: Cristiane de Melo Cazal, et al.
Published: (2014-01-01)

Role of Si and C Impurities in Yellow and Blue Luminescence of Unintentionally and Si-Doped GaN
by: Feng Liang, et al.
Published: (2018-12-01)

Hebron. Purity and the Impure in the Exclusionary City
by: Aide Esu
Published: (2015-06-01)

N-nitrosamine Impurities in Medicines: Toxicity, Formation Pathways, Methods of Determination, and Limits (Review)
by: P. P. Shchetinin, et al.
Published: (2020-11-01)

Distribution of concentration of impurities and "impurity–vacancy" complexes beyond the range of ions during implantation
by: V. I. Sugakov, et al.
Published: (2017-08-01)